To study health-related quality of life (HRQL) in a clinically selected sample of obese outpatients. DESIGN: A single-strand before and after study with 2-y follow-up after treatment comprising 10 weeks on very-low-energy diet (VLED) and 4 months of behaviour modification in groups. SUBJECTS: A total of 126 (mean (s.d.) age 48.2 (11.1) y and body mass index 42.8 (6.2) kg/m 2 obese patients (63% women) referred for treatment in an obesity clinic. MEASUREMENTS: Weight and HRQL using questionnaires (RAND 36-Item Health Survey 1.0 and Obesity-related Psychosocial problems scale (OP-scale)). RESULTS: A total of 100 patients (61% women) completed the treatment and 67 (71% women) completed the 2-y follow-up. The mean (s.d.) weight loss was 12.5 (5.6)% at the end of group therapy, 6.0 (7.1)% at 1 y, and 2.6 (7.5)% at 2 y. At baseline, the mean (s.d.) score for the OP-scale was 61.9 (24.6). The mean scores on every RAND-36 scale were markedly lower than in the Finns without chronic conditions. All the scales in HRQL improved markedly during the treatment. During the follow-up, all the scales started to return towards baseline levels, and at 2 y only obesity-related psychosocial problems and physical functioning were still improved relative to baseline. In categories of weight change at 2 y (Z10% weight loss, 0-9.9% weight loss, weight gain), obesity-related psychosocial functioning, physical functioning, and general health showed dose-response improvement with increasing weight loss. A Z10% weight loss at 2 y after treatment was associated with clear improvement in obesity-related psychosocial problems, physical functioning, physical role functioning, bodily pain, general health, mental health, and vitality. A 0-9.9% weight loss was associated with improvement in obesity-related psychosocial problems and physical functioning. Weight gain was associated with improvement in obesity-related psychosocial problems and social functioning. The study population was too small to examine possible gender differences. CONCLUSIONS: Treatment with VLED and behaviour modification produces marked short-term weight loss and clear improvement in all aspects of HRQL. At 2 y after treatment, the average maintained weight loss is modest. However, 1/3 of patients maintained a Z5% weight loss. Improvement in obesity-related psychosocial problems and physical functioning is associated even with less than 10% of maintained weight loss. Since the pattern of HRQL changes only partly followed the pattern of weight change as expected, other factors, such as the therapeutic effect of participating in the weight loss programme or increase in physical activity, may affect HRQL responses.
Introduction
In population-based cross-sectional studies, an increasing degree of obesity has been associated with compromised health-related quality of life (HRQL), especially physical functioning. [1] [2] [3] [4] [5] [6] [7] [8] [9] Compared with the obese not seeking treatment, obese individuals applying for treatment in weight loss programmes have an even more impaired HRQL. 10, 11 Intentional weight loss reduces blood pressure and improves the metabolic profile. 12 It also reduces the symptoms and/or improves the clinical findings in several obesity-related chronic conditions, such as diabetes, 12 coronary heart disease, 13 asthma, 14, 15 obstructive sleep apnoea, [16] [17] [18] and osteoarthrosis. 19, 20 The marked weight loss achieved by surgical techniques has been associated with clear long-term improvements in HRQL. [21] [22] [23] [24] [25] [26] [27] The previous weight loss studies with lifestyle intervention have shown various improvements in HRQL, but the studies have usually been very short in duration. [28] [29] [30] [31] Studies with longer follow-up have shown a more modest improvement in HRQL, 32 and to our knowledge there are no reports of follow-up over 1 y. Very-low-energy diets (VLED) produce rapid and marked initial weight losses of 12-35 kg in 8-16 weeks. 33 Initially, marked weight loss may be significant in improving longterm weight loss maintenance. 34 The aim of this study was to examine HRQL in obese hospital outpatients before and after treatment with VLED and behaviour modification, and to examine whether beneficial changes in HRQL can be maintained up to 2 y.
Patients and methods

Study design and selection of patients
This was a single-strand before and after study among outpatients in two obesity clinics at Helsinki University Central Hospital. General/occupational practitioners or hospital specialists referred all patients for weight loss treatment. Referral criteria included a body mass index (BMI) Z35 kg/m 2 , failure of previous weight loss attempts, presence of obesity-related comorbidity requiring weight loss, and motivation to take part in a structured weight loss programme.
An endocrinologist examined the patients and evaluated suitability for treatment. Patients were excluded if they had obesity due to a secondary aetiology, had significant psychiatric disorders, had severe eating disorders, were eligible for bariatric surgery, or preferred individual weight loss therapy. In order to assure motivation, all eligible patients were asked to consider taking part in our programme for a few weeks before making their final decision to sign in.
The treatment comprised 10 weeks on VLED and 17 weekly group visits with behaviour modification. The eight groups in this study were carried out in 1999-2000. After therapy, there was no maintenance programme at the obesity clinic; the patients were free to contact their own general/occupational clinic if necessary. However, we invited the patients for follow-up visits at the obesity clinic at 1 and 2 y after the end of treatment. Figure 1 presents the study design and patient flow.
Weight loss programme
During the 4-month weight loss programme, the patients attended 17 weekly 1.5-h behaviour modification group sessions led by a nurse and/or a clinical nutritionist. The behaviour modification programme is based on the LEARN Programme for Weight Control. 35 The core elements of behaviour modification are goal setting, nutrition (decrease in fat intake and increase in complex carbohydrates and fibre intake), exercise (mainly lifestyle exercise), self-monitoring, stimulus control, problem solving, cognitive restructuring, and relapse prevention. The patients received VLED as their only diet for 10 weeks (study weeks [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . The diet provided 52 g of protein, 64 g of carbohydrates, 8 g of fat, vitamins, trace elements, and minerals daily with an energy intake of 2200 kJ/day. A small amount of low-energy vegetables was allowed. A normal diet was gradually introduced during week 12.
Study assessments
The following assessments were made at baseline, the end of group visits (at 4 months) as well as at 1 and 2 y after treatment.
Anthropometry. We measured the patients' height, weight (with a calibrated electronic scale), and calculated the BMI (kg/m 2 ).
Questionnaires. The obesity-specific Obesity-related Psychosocial problemms scale (OP-scale) 36 The questions on exercise and physical activity covered the duration of physical activity while commuting between home and work (six-point scale from never to 41 h daily), the frequency of leisure-time exercise with sweating or getting out of breath (six-point scale from never to daily), and the duration of physical activity associated with household and other domestic activities (six-point scale from o15 min daily to 41 h daily).
Statistics
All data were analysed with SPSS 10.0. for Windows. The baseline characteristics were determined in the population of patients entering treatment. Independent samples' t-test compared the continuous variables and the w 2 test compared the categorical variables between subgroups. For longitudinal analyses, we used the data from 2-y follow-up completers. We used the general linear model for repeated measures with a factor for comparisons within subjects (each follow-up measurement was compared to baseline).
Pearson's correlation examined the baseline scores of HRQL questionnaires and early changes in these scores in relation to weight loss at 2-y.
Ethical issues
The Helsinki University Central Hospital and Peijas Hospital Ethical Committees approved the study protocol and the informed consent form, which subjects signed after having received written and oral information. Table 1 presents the baseline characteristics of the 126 patients entering treatment. The mean BMI did not differ between sexes, but the mean waist circumference was significantly larger in men. Type II diabetes, dyslipidaemia, hypertension, and sleep apnoea were more prevalent among men. Degenerative joint diseases were clearly more common Quality of life in obese outpatients losing weight J Kaukua et al among women. A larger proportion of men had higher than basic education (54 vs 33%, P ¼ 0.030) There were no gender differences in employment status (79 vs 71% in men vs women) and smoking (26 vs 22% in men vs women). Alcohol consumption was more frequent among men (45 vs 24% using alcohol at least once a week, P ¼ 0.003). Figure 1 shows the patient flow. Of the 126 patients entering treatment, 26 (21%) dropped out during treatment. Dropouts were slightly younger than treatment completers (44.1 (10.0) vs 49.3 (11.2) y, P ¼ 0.033). Employed patients were less likely to drop out (employment rate 52% in dropouts and 77% in treatment completers, P ¼ 0.004). Dropouts did not differ from completers in any other characteristic presented in Table 1 or in any HRQL scale score at baseline.
Results
Subjects
A total of 100 patients completed the treatment, and the subsequent dropout rate was 14% by year 1 and 33% by year 2 (67 completed the 2-y follow-up amounting to 53% of those entering treatment). There were no differences in baseline BMI, demographic characteristics, or HRQL between those lost to and those completing follow-up. Also the weight loss and HRQL changes during treatment were similar in these two subgroups.
HRQL at baseline
At baseline, the patients' mean (s.d. ) score for the OP-scale was 61.9 (24.6). A total of 18% showed mild (score o40), 20% showed moderate (score 40-59), and 62% showed severe to extreme (score Z60) impairment in psychosocial functioning. The mean scores on every RAND-36 scale were markedly lower than in the Finnish general population (Table 2 ) and were comparable (with r5 point differences) to the mean scores of Finns with chronic conditions. However, there were two exceptions: the patients scored markedly lower on physical functioning and general health than the Finns with chronic conditions (57.1 (24.1) vs 79.1 (22.8) and 49.4 (20.1) vs 58.1 (20.0), respectively).
Weight changes during the study The mean (s.d. ) weight loss was 14.6 (7.0) kg at the end of group visits, 7.1 (8.8) at 1 y, and 3.3 (9.3) at 2 y. The relative weight loss (% of baseline weight) was 12.5 (5.6), 6.0 (7.1), and 2.6 (7.5), respectively ( Figure 2 ). There were no statistically significant differences between sexes in mean weight change during the study. During the 2-y follow-up after treatment, the mean (s.d.) regain of lost weight was 65.8 (138.4)%.
Obesity-specific HRQL changes
The decrease in the score of the OP-scale measuring obesityrelated psychosocial problems peaked at the end of therapy, and this improvement in psychosocial problems was maintained up to 2 y despite the weight regain ( Figure 2 ).
Generic HRQL changes
All the scale scores in RAND-36 increased during the 4-month treatment. The increase in the scores of physical HRQL scales peaked at the end of therapy, but the scores started to decline thereafter ( Figure 3 ). The largest increase Quality of life in obese outpatients losing weight J Kaukua et al was in the physical functioning scale. At the 1-y follow-up visit, the mean increases in physical functioning, physical role functioning, bodily pain, and general health were still higher than at baseline, but not all scales showed statistical significance relative to baseline. At the 2-y follow-up visit, only the increase in physical functioning was significant relative to baseline all other scores had returned to baseline levels.
Since the physical functioning score was still increased at the 2-y follow-up, we analysed each question in this scale separately (Table 3 ). The lowest mean scores were on vigorous activities and climbing several flights of stairs. The mean score was under 50 for bending or kneeling and walking 2 km. Walking 100 m had the highest mean score at baseline. The mean scores of every question in physical functioning peaked at the end of therapy and most scores remained at higher level throughout the 2-y follow-up, although most of them started to decline towards baseline levels after treatment.
The increases in mental HRQL scales also peaked at the end of therapy, but started to return towards baseline levels similar to the physical HRQL scales (Figure 4) . The largest increase was in the vitality scale. At the 1-y follow-up visit, the scores of mental health, emotional role functioning, vitality, and social functioning were still higher than at baseline, but not all scales showed statistical significance relative to baseline. All the scores of mental and social HRQL returned to baseline levels at the 2-y follow-up visit. 
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At the end of group visits, 76% patients reported improved health and only 4% reported worsened health since the previous year. The respective frequencies were 36 and 27 at 1 y and 15 and 31 at 2 y (note: at 2 y, patients make comparisons to the situation at 1-y follow-up).
Self-reported physical activity
The proportion of patients reporting Z15 min of physical activity (walking, cycling, etc) while commuting between home and work was 30, 24, 42 , and 34% at baseline, end of group visits, at 1 y, and 2 y, respectively. Leisure-time exercise with sweating or getting out of breath at least twice a week was reported by 25% at baseline, 21% at the end of group visits, 43% at 1 y, and 34% at 2 y. A proportion of 72, 85, 82, and 78% of patients reported Z15 min of physical activity associated with household and other domestic activities daily at baseline, end of group visits, 1 y, and 2 y, respectively. Figures 5 and 6 present the mean HRQL changes in categories of weight change (weight gain, 0-9.9% weight loss, and Z10% weight loss). The mean (s.d.) change in weight at the 2-y follow-up in these categories was +4.4 (4.2), À4.0 (3.0), and À16.1 (5.6)% of baseline weight, respectively.
HRQL in categories of weight loss
The obesity-related psychosocial problems (OP-scale) decreased in all weight change categories. The decrease was larger with the larger weight loss: the mean (s.d.) change in score was À6.1 (9.8) with weight gain, À13.5 (17.3) with 0-9.9% weight loss, and À33.9 (23.6) with Z10% weight loss.
There was a linear dose-response effect in the increase of physical functioning and general health scores with increasing weight loss category. Over 10% weight loss was needed to improve physical functioning, physical role functioning, bodily pain, and general health. Mental health and especially vitality scores also increased only with Z10% weight loss. Emotional role functioning was not associated with the amount of weight lost. Social functioning made an interesting exception: the mean score increased 45 points with weight gain, but weight loss did not affect the score.
HRQL as a predictor of long-term weight loss maintenance The baseline OP-scale and RAND-36 scores were not correlated to 1 or 2 y weight loss (% of baseline weight), except for social functioning (r ¼ À0.277, P ¼ 0.032): higher scores at baseline were associated with larger weight loss at 2 y.
HRQL score changes during treatment were not associated with weight loss at 2 y, except for obesity-related psychosocial problems (r ¼ 0. Figure 6 Changes in health-related quality of life (RAND-36) in categories of weight loss at the 2-y follow-up (n ¼ 21 for weight gain, 37 for 0-9.9% weight loss, and 9 for Z10% weight loss). Over five point changes are considered clinically significant.
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Discussion
In this single-strand before and after study with obese outpatients, VLED and behaviour modification produced marked weight loss (12. 5%) and wide-range improvements in HRQL in the short term. However, with longer follow-up after treatment, weight loss maintenance on average was only modest with mean regain of 2/3 lost weight in 2 y. Similar to weight loss, the improvements in HRQL started to diminish, and after 2 y, on average, only obesity-related psychosocial problems and physical functioning showed maintained improvement. Not only weight loss, but other factors such as the therapeutic effect of taking part in a weight loss programme or increase in exercise and physical activity promoted by behavioural modification might have been the cause of improved HRQL. In this study, 1/3 of follow-up completers showed Z5% maintained weight loss at 2 y. Modest weight loss (o10%) was enough to improve obesity-related psychosocial problems and physical functioning. The subgroup with Z10% maintained weight loss experienced a cluster of maintained positive HRQL changes relative to baseline: improvement in obesity-related psychosocial problems, physical functioning, physical role functioning, bodily pain, general health, mental health, and vitality. There was a dose-response effect between weight loss and improvement on obesity-related psychosocial functioning, physical functioning, and general health.
Patients and HRQL at baseline
This study population is a real-life group of patients in two specialist obesity clinics. The patients were middle-aged, with E70% employment rate. Only 5% were on a longer sick leave. However, the prevalence of obesity-related comorbidity was high. The mean BMI did not differ between sexes, but men had significantly larger waist circumference: also the prevalence of diabetes, dyslipidaemia, hypertension, and sleep apnoea were higher among men. In the present study, the population was too small to examine gender differences in HRQL responses.
At baseline, the mean (s.d.) score of the OP-scale was 61.9 (24.6) and 62% of patients entering treatment showed severe to extreme impairment in psychosocial functioning. Our patients scored significantly lower in all the scales in RAND-36 compared to the scores in Finns without chronic conditions and the patients' scores were comparable to the Finns with chronic conditions. In other observational population-based studies, increasing degree of obesity has been associated with impaired HRQL, especially physical functioning. Mental HRQL has been adversely affected by morbid obesity, 36 comorbid conditions, 7 eating disorders, 40 and pain. 41 Sex, level of obesity, treatment seeking status, and modality of future treatment have all been associated with obesity-specific HRQL: the morbidly obese women seeking surgical weight loss treatment have the lowest HRQL scores.
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Weight loss with VLED and behaviour modification Typically, patients lose weight markedly with VLED, but weight loss maintenance in longer follow-up is variable. A meta-analysis of American weight loss studies reported better weight loss maintenance with VLED than with hypoenergetic diets. 34 The Finnish experience is that 38-54% of treatment completers maintain 45% weight loss at 2 y of follow-up. 42, 43 The weight loss results in this study do not contradict previous findings.
HRQL changes during the study In this study, it is evident that not all changes in HRQL concur with changes in weight. In the 2-y follow-up, obesityrelated psychosocial problems and physical functioning stayed at a more improved level than was expected by the pattern of weight change. In categories of weight loss, only obesity-related psychosocial functioning, physical functioning, and general health showed larger improvement with larger weight loss. The OP-scale has shown a dose-response effect with weight loss in previous studies.
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Improved HRQL was not always associated with weight loss; on the contrary, obesity-related psychosocial problems and social functioning improved also among those with weight gain since baseline. This study is unable to examine reasons for this HRQL change, but intra-and interpersonal changes triggered by treatment, weight loss, group support, and subsequent weight maintenance period may hold the answer to this phenomenon. However, it is of importance that after treatment, HRQL seems not to deteriorate among those unsuccessful at weight loss maintenance.
In clinical studies, the improvement of glycaemic control with loss of hyperglycaemic symptoms has also been shown to improve HRQL. 44 In our population, our pleliminary analyses of the metabolic data suggest that the glycaemic control improved among type II diabetics after the marked weight loss with VLED (data not shown). This may have an effect on the HRQL changes documented in this study, but the population was too small to allow subgroup analyses comparing the HRQL changes between those with and without comorbidity (diabetes, sleep apnoea, degenerative joint disease, etc).
Benefits and limitations
The clear benefit of this study lies in the 2-y follow-up after treatment with repeated measuring of HRQL. This segregates the short-and long-term effects of weight loss treatment on HRQL. Previous studies with nonsurgical weight loss intervention examining HRQL have usually been very short in Samsa et al 45 combined two sibutramine studies among obese subjects with medicated hypertension with a 52-week follow-up, and showed statistically significant associations with weight loss and physical functioning, physical role functioning, vitality (SF-36), and mobility and activities of daily life (Impact of Weight on Quality of Life questionnaire). We have previously shown in a randomised clinical trial with obese men that marked weight loss with VLED and behaviour modification led to many HRQL improvements in the short term, but with longer follow-up (nearly 6 months after treatment) only physical functioning, social functioning, and obesity-related psychosocial problems showed maintained improvement. 32 The local guidelines recommend referring obese patients to obesity clinics only if the patient has a BMI Z35 kg/m 2 with obesity-related comorbidity requiring weight loss and if previous attempts to lose weight have failed.
However, approximately 1/3 of the referred patients did not enter treatment with VLED and behaviour modification, making this a highly selected population. Therefore, caution is advisable when generalising these results, as the HRQL benefits reported in this study may be different from those in healthier obese populations seeking weight loss. Also, the study's ''single-strand before and after'' design does not allow comparisons to a control group, which limits the conclusions on true treatment effect. However, HRQL was measured with adequately constructed questionnaires further validating the results in this study. The repeated measurement of multiple outcomes poses the possibility of statistically significant differences without true effect. Therefore, the less markedly significant results (P-values 0.01-0.05) merely indicate possible treatment effects and need to be explored in further studies with larger populations.
In conclusion, the patients of an obesity clinic losing weight with VLED and behaviour modification achieve clinically significant weight loss and HRQL benefits over 2 y. Maintained weight loss o10% improves obesity-related psychosocial problems and physical functioning, and Z10% is associated with a cluster of HRQL benefits. Since the metabolic benefits of weight loss are well established, evidence on improvement in HRQL may further motivate the policy makers, health care personnel, and patients to tackle the problem of obesity, weight loss, and weight loss maintenance.
